By otakuyassine3@gmail.com 
CVS Health Co. (NYSE:CVS – Get Free Report)’s share price traded down 0.6% during trading on Tuesday . The company traded as low as $50.93 and last traded at $51.22. 3,163,712 shares traded hands during mid-day trading, a decline of 77% from the average session volume of 13,606,966 shares. The stock had previously closed at $51.52.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the company. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. UBS Group boosted their price target on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday, November 7th. Truist Financial dropped their price objective on shares of CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Finally, TD Cowen boosted their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $68.71.
Get Our Latest Research Report on CVS Health
CVS Health Stock Performance
The firm has a market cap of $65.44 billion, a PE ratio of 13.20, a PEG ratio of 0.72 and a beta of 0.59. The company has a 50-day simple moving average of $51.49 and a two-hundred day simple moving average of $56.39. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.
CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.21 earnings per share. As a group, equities research analysts forecast that CVS Health Co. will post 5.22 earnings per share for the current year.
CVS Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 5.11%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the business. Ballentine Partners LLC grew its position in shares of CVS Health by 17.5% in the fourth quarter. Ballentine Partners LLC now owns 5,314 shares of the pharmacy operator’s stock valued at $239,000 after purchasing an additional 793 shares in the last quarter. LaFleur & Godfrey LLC boosted its stake in CVS Health by 49.9% in the 4th quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator’s stock worth $217,000 after purchasing an additional 1,610 shares during the period. AHL Investment Management Inc. increased its position in shares of CVS Health by 1.7% during the fourth quarter. AHL Investment Management Inc. now owns 43,316 shares of the pharmacy operator’s stock valued at $1,944,000 after buying an additional 713 shares during the period. M.E. Allison & CO. Inc. purchased a new stake in shares of CVS Health in the fourth quarter worth about $277,000. Finally, Diversify Wealth Management LLC grew its stake in CVS Health by 2.6% during the fourth quarter. Diversify Wealth Management LLC now owns 16,181 shares of the pharmacy operator’s stock valued at $777,000 after acquiring an additional 408 shares in the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Stories
Receive News & Ratings for CVS Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CVS Health and related companies with MarketBeat.com’s FREE daily email newsletter.